Biggest pharmaceuticals merger on verge of collapsing,but drugmakers say in joint statement that they are reviewing US Treasury’s unique rulesThe largest pharmaceuticals merger in history, between Pfizer and Allergan, or could be abandoned after the US government took fresh steps to clamp down on tax avoidance deals.
The $160bn deal,announced in November, was thrown into doubt following the move by the US Treasury on Monday to construct so-called tax inversion deals, and by which corporations relocate their headquarters to countries with a lower tax rate,less financially appealing.
Continue reading...
Source: theguardian.com